Tango Therapeutics Inc (TNGX)
7.82
+0.21
(+2.76%)
USD |
NASDAQ |
May 06, 13:58
Tango Therapeutics Price to Book Value: 3.297 for May 6, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 3.209 |
| May 02, 2024 | 3.200 |
| May 01, 2024 | 3.070 |
| April 30, 2024 | 3.247 |
| April 29, 2024 | 3.318 |
| April 26, 2024 | 3.137 |
| April 25, 2024 | 3.091 |
| April 24, 2024 | 3.272 |
| April 23, 2024 | 3.276 |
| April 22, 2024 | 3.082 |
| April 19, 2024 | 3.082 |
| April 18, 2024 | 3.107 |
| April 17, 2024 | 3.145 |
| April 16, 2024 | 3.099 |
| April 15, 2024 | 3.086 |
| April 12, 2024 | 3.103 |
| April 11, 2024 | 3.200 |
| April 10, 2024 | 3.150 |
| April 09, 2024 | 3.247 |
| April 08, 2024 | 3.133 |
| April 05, 2024 | 3.112 |
| April 04, 2024 | 3.221 |
| April 03, 2024 | 3.238 |
| April 02, 2024 | 3.188 |
| April 01, 2024 | 3.221 |
| Date | Value |
|---|---|
| March 28, 2024 | 3.348 |
| March 27, 2024 | 3.247 |
| March 26, 2024 | 3.166 |
| March 25, 2024 | 3.217 |
| March 22, 2024 | 3.259 |
| March 21, 2024 | 3.466 |
| March 20, 2024 | 3.584 |
| March 19, 2024 | 3.436 |
| March 18, 2024 | 3.538 |
| March 15, 2024 | 3.807 |
| March 14, 2024 | 3.833 |
| March 13, 2024 | 3.887 |
| March 12, 2024 | 4.216 |
| March 11, 2024 | 4.337 |
| March 08, 2024 | 4.502 |
| March 07, 2024 | 4.450 |
| March 06, 2024 | 4.563 |
| March 05, 2024 | 4.510 |
| March 04, 2024 | 4.660 |
| March 01, 2024 | 4.619 |
| February 29, 2024 | 4.494 |
| February 28, 2024 | 4.648 |
| February 27, 2024 | 4.765 |
| February 26, 2024 | 4.591 |
| February 23, 2024 | 4.644 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9582
Minimum
Sep 26 2022
39.20
Maximum
Sep 17 2021
3.829
Average
2.400
Median
Price to Book Value Benchmarks
| Aquestive Therapeutics Inc | -- |
| 2seventy bio Inc | 0.9828 |
| NovaBay Pharmaceuticals Inc | 2.004 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7463 |
Price to Book Value Related Metrics
| PS Ratio | 20.23 |
| Price | 7.82 |
| Earnings Yield | -13.81% |
| Market Cap | 834.54M |